Recruitment: UK offers approximately $ 800 to volunteers for the first COVID-19 vaccine human trial

This week, the UK is recruiting volunteers aged 18-55 for one of the first vaccines against Coronavirus Disease 2019 (COVID-19).

According to daily mail“Imperial College London is looking for volunteers to try another vaccine within the next few weeks. Anyone between the ages of 18 and 55 who is healthy will be able to contact Imperial College London, Southampton University Hospital, Bristol Children’s Vaccine Center. Can participate in. “

This study will test whether vaccination with the Oxford vaccine ChAdOx1 nCoV-19 is effective against COVID-19.

The first part of the exam will include 510 volunteers out of 1,112. The exam will then include a senior group. Test safety and immune response to vaccines.

The study volunteers will be divided into two parts: the first half will get the new coronavirus vaccine and the other half will get the meningitis vaccine. They don’t know what vaccine they will receive.

Andrew Pollard, a member of the Oxford team, feels potential results in their work. “With most vaccines, the immune system in the elderly, especially those over the age of 70, does not have such a good response,” he said.

Read now: The fate of dying: roundworms have self-destruction programs to reduce colony food demand

No more monkey business

The new jab is based on an adenovirus that causes a cold. It was taken from a chimpanzee and damaged, so it won’t make humans ill.

Scientists have genetically engineered the virus to “make the” spike “proteins found outside the COVID-19 virus, essential for its ability to infect people.” According to daily mail.

Once the vaccine works, the body already knows how to attack proteins outside the virus, so vaccinated people won’t catch COVID-19. “Thus, the immune system can, in theory, destroy it before it causes symptoms.” Added daily mail

“Usually it will take years to reach this stage and I am very proud of the work done so far.”

definitely

Each volunteer is awarded $ 235 to $ 772 for participation in the study, the first human vaccine trial in the UK against COVID-19. Secretary of Health Matt Hancock said he “throwed” all British attempts to develop the first COVID-19 vaccine.

Read now: Scientists Announce Breakthrough “Bath Sponge” for Automobiles That Can Store More Gas Without the Need for Expensive and Huge Tanks

Mr Hancock added that the government will give Oxford scientists an additional $ 24.7 million to support the trial, while Imperial College London will receive $ 27.8 million for one of the projects. Researchers are confident that large-scale production of the vaccine may occur in September.

ChAdOx1 nCoV-19 is the first UK vaccine to be tested. The government wants to abolish domestic COVID-19, which has infected more than 125,000 people and killed more than 17,000 people.

The next trial lasts six months and is limited to a very small number of people. This helps scientists evaluate whether the vaccine is safe and working without wasting unnecessary resources.

According to daily mail“Each patient must return for 4 to 11 visits after the jab, and if something goes wrong, many people are not at risk.”

Hancock said the vaccine could take years to develop. However, if the jab is successful, it can strengthen its manufacturing and production and go public more quickly.

Leading the vaccine race

Oxford Vaccine Group and Imperial College London are the world’s leading vaccine developers. “The United Kingdom is at the forefront of global efforts, spending more money on global exploration of vaccines than any other country,” said the Secretary of Health.

The Jenner Institute at Oxford University and the Oxford Vaccine Group began developing the vaccine in January. It took four months to develop the Oxford vaccine instead of five. “They already have a similar coronavirus base vaccine.” According to daily mail.

According to Pollard, their team “has already got a head start on recent coronaviruses such as SARS and MERS.”

“Usually, it will take years to reach this stage, and I am very proud of my work,” said Hancock.